
|Articles|November 1, 2003
Facial Filler Study Shows Less is More
New Orleans - Calcium hydroxylapatite is similar to other dermal fillers in terms of efficacy and ease of administration, but less of it is necessary to get the job done, according to a Stanford University-based retrospective, prospective study. The study was performed by Hayes B. Gladstone, M.D., director, dermatologic surgery, Stanford University, Palo Alto, Calif., in conjunction with Mountain View, Calif., private practice dermatologic surgeon Greg S. Morganroth, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
What Counts as “Short-Term” Systemic Corticosteroids in Atopic Dermatitis, and Why It Matters
3
Targeting MRGPRX2: Early Human Data for a Novel CSU Approach
4
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
5










